Gallarate Marina, Serpe Loredana, Foglietta Federica, Zara Gian Paolo, Giordano Susanna, Peira Elena, Chirio Daniela, Battaglia Luigi
Universita degli Studi di Torino, Dipartimento di Scienza e Tecnologia del Farmaco, Via Pietro Giuria 9, Torino, Italy.
Protein Pept Lett. 2014;21(11):1157-62. doi: 10.2174/0929866521666140806164410.
FMOC-isocyclosporine A, a fluorescent labeled cyclosporine A, was encapsulated in solid lipid nanoparticles (SLN) prepared by the coacervation technique, and its anti-inflammatory activity was evaluated. The anti-inflammatory activity of the fluorescent labelled molecule, measured as inhibition of TNF-α secretion, is similar to the native one. SLN were compared to commercial formulations, through measurement of cytokine release and drug uptake in rat peripheral blood mononuclear cells. Drug-loaded SLN inhibit TNF-α secretion in a lower extent than commercial formulations, probably due to a lower uptake by the cells, but the increase of IL-10 secretion caused by the lipid matrix itself makes this formulation interesting for its anti-inflammatory activity.
芴甲氧羰基-异环孢素A(一种荧光标记的环孢素A)被包裹于通过凝聚技术制备的固体脂质纳米粒(SLN)中,并对其抗炎活性进行了评估。以抑制肿瘤坏死因子-α(TNF-α)分泌来衡量,荧光标记分子的抗炎活性与天然分子相似。通过测量大鼠外周血单核细胞中的细胞因子释放和药物摄取,将SLN与市售制剂进行了比较。载药SLN抑制TNF-α分泌的程度低于市售制剂,这可能是由于细胞摄取较少,但脂质基质本身引起的白细胞介素-10(IL-10)分泌增加使得该制剂因其抗炎活性而具有吸引力。